ZONALTA 8MG TABLET contains Endoxifen, which belongs to the group of medicines called protein kinase C inhibitors. It is used in the management of acute manic episodes with or without mixed features of bipolar I disorder. Bipolar I disorder is a psychiatric condition that causes changes in mood (from low to high), activity levels, energy and the ability to perform everyday tasks.
ZONALTA 8MG TABLET is not recommended for use in patients with deep vein thrombosis or pulmonary embolism. ZONALTA 8MG TABLET should be used with caution in patients with
irregular menses (in women), uterus or endometrial cancer, breast cancer, endometriosis, uterine fibroids, ovarian cysts and cataracts. Avoid consuming grapefruit juice while taking ZONALTA 8MG TABLET.
ZONALTA 8MG TABLET is not recommended for use in pregnant women and females of reproductive potential should use effective contraception for 2 months after the last dose of ZONALTA 8MG TABLET. Do not breastfeed the baby during the management and for 3 months after taking the last dose of ZONALTA 8MG TABLET. The safety and effectiveness of ZONALTA 8MG TABLET in children and elderly patients have not been established.
The most common side effects of taking ZONALTA 8MG TABLET are insomnia, headache, nausea, vomiting, indigestion, decreased appetite, delusions and worsening of mania. Contact your physician if any of your symptoms get worse or persist.
No content available
